Subsidy for vaccine patches

MyLife Technologies has received a Take-off subsidy from the Ministries of Education, Culture and Science (OCW) and Economic Affairs (EZ). On behalf of Eindhoven University of Technology,  dr. Regina Luttge, associate professor in the research group Microsystems, is involved in MyLife Technologies as CSO (Chief Scientific Officer).

MyLife Technologies makes patches with hundreds of micro-needles, that can apply a vaccine through the skin of a patient. These needles are so small that the patient will not feel anything. A special feature of the needles of MyLife Technologies is that they are made of a porous ceramic material and that the pores, through which the vaccine is applied, are only a few millionths of a millimeter in size. MyLife Technologies can use the Take-off subsidy to develop a first proof-of-concept in an animal study.


Key to the success of MyLife Technologies is the development of a cost-effective micro-fabrication method of the needles. The task of dr. Luttge is to fuel this development, but also to characterize the needles. Characterization of the mechanical and fluidic properties of these high-tech needles is a challenge, but important in order to develop a medical device, where the patch not only sticks to the skin but in which the patient can apply the drug safely.

The involvement of dr. Luttge in MyLife Technologies as TU/e researcher provides many interesting opportunities for TU/e students. Dr. Luttge explains, “The students can use their knowledge and skills while working on a project that really has an impact on the success of the start-up. MyLife Technologies is a good example of the growing interaction between teachers, students and business. It gives the students the opportunity to learn and to contribute during an innovation process. Something to which the TU/e assigns great value.”

Take-off subsidy

Besides MyLife Technologies, 7 other new companies also receive a Take-off subsidy. This subsidy (€ 250,000) should help these start-ups to secure more funding from external companies. The external funding is necessary to convert the scientific knowledge of innovative start-ups into commercial applications. Sander Dekker, State Secretary for Education, Culture and Science, believes these eight start-ups are clear examples of scientific knowledge with a huge added value for society and economy.